Carbone Cancer Center, University of Wisconsin

Site:	Carbone Cancer Center, University of Wisconsin
Address:
City:	Madison
State:	WI
Zip:	53792
Country:	USA

Phase	Trial	Trial Status	Site Status	Drug	NCT#
1/2	Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors	Terminated	Closed	CB-839 + Talazoparib	NCT03875313
3	(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors	Recruiting	Active	Bezuclastinib plus Sunitinib	NCT05208047
1	Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients	Ongoing, but not recruiting	Closed	BEZ235 + MEK162	NCT01337765
1	Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid Tumors	Completed	Closed	Vorinostat + Bortezomib	NCT00227513